Bronchorelaxation of the human bronchi by CFTR activators

Pulmonary Pharmacology and Therapeutics

Volumn 27, Issue 1, 2014, Pages 38-43

  Norez, Caroline ^a   Jayle, Christophe ^b   Becq, Frédéric ^a   Vandebrouck, Clarisse ^a  

^a UNIVERSITÉ DE POITIERS   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

CFTR; Human airway; Pharmacology; Relaxation; Smooth muscle

Indexed keywords

2' DEOXYADENOSINE METHYLGLYOXAL ADDUCT 5A; 5 BUTYL 7 CHLORO 6 HYDROXYBENZO[C]QUINOLIZINIUM CHLORIDE; BRONCHODILATING AGENT; CARBACHOL; CHLORIDE CHANNEL; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FORSKOLIN; GENISTEIN; IODINE 125; SALBUTAMOL; THEOPHYLLINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRONCHODILATATION; BRONCHODILATING ACTIVITY; BRONCHUS MUCOSA; BRONCHUS MUSCLE; CANCER TISSUE; CHLORIDE TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG POTENCY; EXPERIMENTAL BRONCHOCONSTRICTION; FEMALE; GENE ACTIVATION; HUMAN; HUMAN BRONCHIAL SMOOTH MUSCLE CELL; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; LUNG CARCINOMA; LUNG LOBECTOMY; LUNG PARENCHYMA; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE RELAXATION;

CFTR; HUMAN AIRWAY; PHARMACOLOGY; RELAXATION; SMOOTH MUSCLE;

AGED; ALBUTEROL; BRONCHI; BRONCHOCONSTRICTION; BRONCHODILATOR AGENTS; CARBACHOL; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; ION TRANSPORT; MALE; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE;

EID: 84892442308     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2013.06.008     Document Type: Article

References (32)

1. Riordan J.R., Rommens J.M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989, 245(4922):1066-1073.
2. Pilewski J.M., Frizzell R.A. Role of CFTR in airway disease. Physiol Rev 1999, 79(1 Suppl.):215-255.
3. Mitchell I., Corey M., Woenne R., Krastins I.R., Levison H. Bronchial hyperreactivity in cystic fibrosis and asthma. J Pediatr 1978, 93(5):744-748.
4. Gadsby D.C., Nagel G., Hwang T.C. The CFTR chloride channel of mammalian heart. Annu Rev Physiol 1995, 57:387-416.
5. - channels in heart. Circ Res 1992, 71(4):1002-1007.
6. Weyler R.T., Yurko-Mauro K.A., Rubenstein R., Kollen W.J., Reenstra W., Altschuler S.M., et al. CFTR is functionally active in GnRH-expressing GT1-7 hypothalamic neurons. Am J Physiol 1999, 277(3 Pt 1):563-571.
7. Tousson A., Van Tine B.A., Naren A.P., Shaw G.M., Schwiebert L.M. Characterization of CFTR expression and chloride channel activity in human endothelia. Am J Physiol 1998, 275(6 Pt 1):1555-1564.
8. Wei L., Freichel M., Jaspers M., Cuppens H., Cassiman J.J., Droogmans G., et al. Functional interaction between TRP4 and CFTR in mouse aorta endothelial cells. BMC Physiol 2001, 1:3.
9. Robert R., Thoreau V., Norez C., Cantereau A., Kitzis A., Mettey Y., et al. Regulation of the cystic fibrosis transmembrane conductance regulator channel by beta-adrenergic agonists and vasoactive intestinal peptide in rat smooth muscle cells and its role in vasorelaxation. J Biol Chem 2004, 279(20):21160-21168.
10. - transport of mouse aortic smooth muscle cells. J Physiol 2005, 568(Pt 2):483-495.
11. Robert R., Savineau J.P., Norez C., Becq F., Guibert C. Expression and function of cystic fibrosis transmembrane conductance regulator in rat intrapulmonary arteries. Eur Respir J 2007 Nov, 30(5):857-864.
12. Divangahi M., Balghi H., Danialou G., Comtois A.S., Demoule A., Ernest S., et al. Lack of CFTR in skeletal muscle predisposes to muscle wasting and diaphragm muscle pump failure in cystic fibrosis mice. PLoS Genet 2009 Jul, 5(7):e1000586.
13. Michoud M.C., Robert R., Hassan M., Moynihan B., Haston C., Govindaraju V., et al. Role of the cystic fibrosis transmembrane conductance channel in human airway smooth muscle. Am J Respir Cell Mol Biol 2009 Feb, 40(2):217-222.
14. Fortner C.N., Lorenz J.N., Paul R.J. Chloride channel function is linked to epithelium-dependent airway relaxation. Am J Physiol Lung Cell Mol Physiol 2001, 280(2):334-341.
15. Vandebrouck C., Melin P., Norez C., Robert R., Guibert C., Mettey Y., et al. Evidence that CFTR is expressed in rat tracheal smooth muscle cells and contributes to bronchodilation. Respir Res 2006, 7:113.
16. Watson N., Magnussen H., Rabe K.F. The relevance of resting tension to responsiveness and inherent tone of human bronchial smooth muscle. Br J Pharmacol 1998 Feb, 123(4):694-700.
17. Norez C., Antigny F., Noel S., Vandebrouck C., Becq F. A cystic fibrosis respiratory epithelial cell chronically treated by miglustat acquires a non-cystic fibrosis-like phenotype. Am J Respir Cell Mol Biol 2009, 41(2):217-225.
18. Renier M., Tamanini A., Nicolis E., Rolfini R., Imler J.L., Pavirani A., et al. Use of a membrane potential-sensitive probe to assess biological expression of the cystic fibrosis transmembrane conductance regulator. Hum Gene Ther 1995 Oct, 6(10):1275-1283.
19. Marivingt-Mounir C., Norez C., Derand R., Bulteau-Pignoux L., Nguyen-Huy D., Viossat B., et al. Synthesis, SAR, crystal structure, and biological evaluation of benzoquinoliziniums as activators of wild-type and mutant cystic fibrosis transmembrane conductance regulator channels. J Med Chem 2004, 47(4):962-972.
20. Routaboul C., Norez C., Melin P., Molina M.C., Boucherle B., Bossard F., et al. Discovery of alpha-aminoazaheterocycle-methylglyoxal adducts as a new class of high-affinity inhibitors of cystic fibrosis transmembrane conductance regulator chloride channels. J Pharmacol Exp Ther 2007 Sep, 322(3):1023-1035.
21. Ma T., Thiagarajah J.R., Yang H., Sonawane N.D., Folli C., Galietta L.J., et al. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest 2002, 110(11):1651-1658.
22. Schultz B.D., Singh A.K., Devor D.C., Bridges R.J. Pharmacology of CFTR chloride channel activity. Physiol Rev 1999, 79(1 Suppl.):109-144.
23. Sheppard D.N., Welsh M.J. Structure and function of the CFTR chloride channel. Physiol Rev 1999, 79(1 Suppl.):23-45.
24. Naren A.P., Cobb B., Li C., Roy K., Nelson D., Heda G.D., et al. A macromolecular complex of beta 2 adrenergic receptor, CFTR, and ezrin/radixin/moesin-binding phosphoprotein 50 is regulated by PKA. Proc Natl Acad Sci U S A 2003 Jan 7, 100(1):342-346.
25. Billet A., Melin P., Jollivet M., Mornon J.P., Callebaut I., Becq F. C terminus of nucleotide binding domain 1 contains critical features for cystic fibrosis transmembrane conductance regulator trafficking and activation. J Biol Chem 2010 Jul 16, 285(29):22132-22140.
26. Frossard N., Muller F. Epithelial modulation of tracheal smooth muscle response to antigenic stimulation. J Appl Physiol 1986, 61(4):1449-1456.
27. Kao J., Fortner C.N., Liu L.H., Shull G.E., Paul R.J. Ablation of the SERCA3 gene alters epithelium-dependent relaxation in mouse tracheal smooth muscle. Am J Physiol 1999, 277(2 Pt 1):264-270.
28. Tschirhart E., Landry Y. Airway epithelium releases a relaxant factor: demonstration with substance P. Eur J Pharmacol 1986, 132(1):103-104.
29. Davis P.B., Drumm M., Konstan M.W. Cystic fibrosis. Am J Respir Crit Care Med 1996, 154(5):1229-1256.
30. Halayko A.J., Amrani Y. Mechanisms of inflammation-mediated airway smooth muscle plasticity and airways remodeling in asthma. Respir Physiol Neurobiol 2003, 137(2-3):209-222.
31. Hays S.R., Ferrando R.E., Carter R., Wong H.H., Woodruff P.G. Structural changes to airway smooth muscle in cystic fibrosis. Thorax 2005, 60(3):226-228.
32. Sparrow M.P., Omari T.I., Mitchell H.W. The epithelial barrier and airway responsiveness. Can J Physiol Pharmacol 1995, 73(2):180-190.